Emergent Biosolutions Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$231,100	$140,900	$222,200	$194,700
Gross Profit	139,400	60,700	119,400	136,500
EBITDA	96,200	23,500	75,200	21,000
EBIT	72,800	500	50,400	-4,300
Net Income	51,200	-12,000	68,000	-31,300
Net Change In Cash	231,100	140,900	222,200	194,700
Free Cash Flow	-5,700	103,500	-14,800	-81,600
Cash	245,500	271,000	149,100	105,600
Basic Shares	56,500	54,200	57,300	54,200

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$1,043,599	$1,049,300	$1,120,900	$1,773,600
Gross Profit	375,400	360,000	427,200	793,200
EBITDA	53,400	-47,000	-34,400	504,200
EBIT	-52,200	-168,100	-166,000	386,000
Net Income	-190,600	-760,500	-223,800	219,500
Net Change In Cash	1,043,599	1,049,300	1,120,900	1,773,600
Cost of Revenue			65,800	-44,900
Free Cash Flow	35,800	-257,900	-149,900	96,100
Cash	99,500	111,700	642,600	576,300
Basic Shares	53,000	51,200	50,100	54,100